RCOR1 and cancer: These findings are consistent with emerging literature implicating transcriptional co-repressors in cancer development, such as RCOR1 and LSD1/CoREST complexes, which are known to modulate chromatin states and transcriptional programs in malignancies (6, 7, 12).